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Objectives: To investigate the prevalence of the vacA, cagA, cagE, iceA, and babA2 genotypes in
Helicobacter pylori strains isolated from Thai dyspeptic patients, and to determine whether any
correlation exists between these genotypes and clinical manifestations.
Methods: Helicobacter pylori was examined in 112 patients (62 with non-ulcer dyspepsia
(gastritis), 34 with peptic ulcer disease, and 16 with gastric cancer (GCA)), detected by culture
or direct detection from gastric biopsies. Allelic variants of the vacA, cagA, cagE, iceA, and babA2
genotypes were identified by using the polymerase chain reaction.
Results: The positive rates for the vacAs1, vacAs2, cagA, cagE, iceA1, iceA2, and babA2 genes in
H. pylori of dyspeptic patients were 100%, 0%, 98.2%, 88.4%, 45.5%, 33.1%, and 92%, respectively.
The allelic variant vacAs1m1 was more prevalent (58%) than vacAs1m2 (42%). The cagA and cagE
genes were commonly found together (87.5%). The most predominant genotypes were vacAs1m1,
cagA, cagE, iceA1, and babA2. The various genes alone or in combination had no statistically
significant association with the clinical outcomes ( p > 0.05).
Conclusion: Neither single gene nor combination of vacA, cagA, cagE, iceA, and babA2 genes was
significantly helpful in predicting the clinical outcome of H. pylori infection in Thai patients. The
high prevalence of these genes in H. pylori isolated from Thai patient groups suggests that H.
pylori strains are geographically dependent.
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Helicobacter pylori is considered an important etiological
agent in the development of gastritis, peptic ulcers and
gastric carcinoma.1,2 The occurrence of such diverse dis-
eases withH. pylorimay depend on specific properties of the
organism, host genetic factors, and environmental factors.3
Althoughmore than 50% of theworld’s population is infected
with H. pylori, a minority of carriers develop serious gastro-
intestinal diseases;3—5 however, increasing evidence sug-
gests that the genetic variability of H. pylori may itself be
of clinical importance.3—7 Several putative genes, such as
vacA, cagA, cagE, iceA and babA, have been identified and
may play important roles in the pathogenesis of H. pylori
infection.8—10
The vacuolating cytotoxin gene (vacA) is present in all H.
pylori strains.4 The vacA genotype comprises a hypervariable
signal sequence and a middle region allele. The vacA sub-
types are determined by the combination of s1a, s1b, s1c and
s2, and m1, m2a and m2b.4,11 Although all strains of H. pylori
contain the vacA gene, they vary in terms of their ability to
produce cytotoxin. Type m1 strains demonstrate more toxic
activity than m2, type s1a is more active than s1b, and type
s2 is less active than s1.6,12
The cytotoxin associated gene A (cagA) has been proposed
as a marker for a genomic pathogenicity island (cag-PAI) of
approximately 40 kbp whose presence is associated with
more severe clinical outcomes.13,14 The cagA-positive H.
pylori strains are known to induce interleukin-8 (IL-8) pro-
duction and mucosal inflammation.13,14 Other members of
cag-PAI have also been evaluated for their involvement in
virulence, and cagE is one of the marker genes in cagI of the
cag-PAI. It is essential for cagA translocation and phosphor-
ylation.15,16 The presence of the cagE gene has also been
associated with a more severe clinical outcome.17
The induced by contact with epithelium (iceA) gene has
recently been discovered. The two main allelic variants of
the gene are iceA1 and iceA2. The expression of iceA1 is up-
regulated on contact between H. pylori and human epithelial
cells, and may be associated with peptic ulcer disease.7,18,19
The blood group antigen-binding adhesin gene (babA) is
involved in the binding activity between bacterial adhesin
and human Lewis-b blood group antigens on gastric epithelial
cells.20 Although three bab alleles have been identified
(babA1, babA2, babB), only the babA2 gene product is
necessary for Lewis-b binding activity. Several researchers
suggest that the presence of babA2 is related to the occur-
rence of peptic ulcers and gastric cancer.20,21
In Thailand, an average 48% of dyspeptic patients are
infected with H. pylori, but a higher prevalence has been
found in gastric ulcer patients and peptic ulcer patients than
in gastritis patients.22—24 Some virulence-related gene pro-
ducts such as VacA and CagA in the isolated strains have been
studied;25,26 however, the involvement of H. pylori geno-
types in specific diseases remains controversial.8,9,21,27 A
mainstream challenge for researchers to identify the parti-
cular H. pylori genes, including vacA, cagA, cagE, iceA, and
babA2, has been elucidated;9 however, no study in Thailand
has simultaneously investigated the prevalence and relation-
ship to clinical outcomes of these putative genes. To under-
stand the clinical relevance of H. pylori genotyping in
predicting infection outcomes, and H. pylori genes in differ-ent geographical regions for the basic knowledge of Thai
dyspeptic patients, we investigated the prevalence of vacA,
cagA, cagE, iceA, and babA2 genes of H. pylori obtained from
112 Thai patients with gastritis, peptic ulcers, and gastric
cancer. The correlation between the genetic status of the




Gastric biopsies and H. pylori isolates were obtained from
112 patients who had undergone routine endoscopy for
symptoms of dyspepsia at the hospitals in central and north-
east Thailand. We included 34 patients with peptic ulcer
disease (PUD; 20 with gastric ulcers (GU), 14 with duodenal
ulcers (DU)), 62 with non-ulcer dyspepsia or gastritis (GT),
and 16 with gastric cancer (GCA). The patients were 55 males
and 57 females with an age range of 18 to 88 years (mean 49.5
years).
The study was approved by the ethics committee of Khon
Kaen University and performed in accordance with the
Declaration of Helsinki. Informed consent was obtained from
each patient prior to entering the study.
Clinical samples and culture
Three gastric mucosal biopsy specimens from the antrum and
corpus were obtained from each patient and divided into
three parts. Both antral and corpus specimens were used for
culture, the rapid urease test (RUT), and histological exam-
ination.
Culture was performed according to the method of
Hazell,28 with modifications. Briefly, each antral and corpus
specimen was immediately placed into Stuart’s transport
medium and brought to the laboratory within 2 h at 4 8C.
Each of the biopsy specimens was homogenized separately in
200 ml of normal saline and cultured on 7% human blood agar
(Difco, Detroit, MI, USA) and brain heart infusion agar (Difco)
containing the supplement SR147 (5 mg/l trimethoprim,
10 mg/l vancomycin, 5 mg/l amphotericin B, 5 mg/l cefsu-
lodin (SR147, OXOID, Unipath Ltd, Basingstoke, UK)). The
plates were incubated at 37 8C under microaerophilic con-
ditions (5% O2, 10% CO2, 85% N2) and were examined after 4
and 7 days of incubation. Characteristic colonies of H. pylori
were confirmed by Gram staining, oxidase, catalase and
urease tests. The H. pylori colonies were further used for
DNA extraction.
Commercial rapid urease test (RUT, Pronto Dry
test)
The RUT was performed according to the manufacturer’s
instructions (Medical Instruments Corp., Solothurn, Swit-
zerland). Briefly, one antral and one corpus specimen
together were directly inoculated onto the commercial
RUT agar gel. The results were observed and recorded
within 24 hours. A positive RUT was indicated when the
color changed from yellow to pink. The positive RUTs were
used for chromosomal DNA extraction if the culture was
negative.
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DNA from 30 H. pylori isolates and 82 of each antrum and
corpus gastric biopsy positive by the RUT, were extracted
using the genomic DNA purification kit (Puregene, Gentra
Systems, USA), according to the manufacturer’s instructions.
Briefly, a loop full of cell culture or the gastric biopsy samples
(obtained from the urease test agar assay homogenized with
200 ml of normal saline) were incubated with 450 ml cell lysis
solution and 2.5 ml proteinase K solution for 3 h at 55 8C. The
lysate was incubated at 98 8C for 10 min and then 2.5 ml
RNase A solution was added to the cell lysate and incubated
at 37 8C for 60 min. Then, 200 ml protein precipitation solu-
tion was added and centrifuged at 13 000 g for 3 min. The
supernatant was collected and 400 ml of 100% isopropanol
was added and centrifuged at 13 000 g for 5 min. The super-
natant was carefully discarded. Then, 300 ml of 70% ethanol
was added to the pellet and centrifuged. The ethanol was
poured off and left to dry for 3 h. Then, 50 ml DNA hydration
solution was added and incubated for 1 h at 65 8C. DNA was
stored at 20 8C until used.
PCR assays for glmM gene and virulence genes
(vacA, cagA, cagE, iceA, babA2)
Primer sequences, sizes, and conditions of PCR amplifications
of the glmM gene29 — for detection and confirmation of H.
pylori — and the virulence genes (i.e., vacA,30,31 cagA,32
cagE,16 iceA7 and babA233), were designed based on pub-
lished papers with a modification of PCR mixtures and PCR
conditions (Table 1).Table 1 Primer sequence and PCR conditions
Genes Primer sequence (50 ! 30) PCR product
(bp)
glmM AAGCTTTTAGGGGTGTTAGGGGTTT 294 93
AAGCTTACTTTCTAACACTAACGC
vacA
s1/s2 ATGGAAATACAACAAACACAC 259/286 94
CTGCTTGAATGCGCCAAAC
s1a GTCAGCATCACACCGCAAC 190 94
CTGCTTGAATGCGCCAAAC
s1b AGCGCCATACCGCAAGAG 187 94
CTGCTTGAATGCGCCAAAC
s1c CTCTCGCTTTAGTGGGGYT 213 94
CTGCTTGAATGCGCCAAAC
m1/m2 CAATCTGTCCAATCAAGCGAG 567/642 94
GCGTCAAAATAATTCCAAGG
cagA ATAATGCTAAATTAGACAACTTGAGCGA 298 94
TTAGAATAATCAACAAACATCACGCCAT
cagE TTGAAAACTTCAAGGATAGGATAGAGC 508 94
GCCTAGCGTAATATCACCATTACCC
iceA1 GTGTTTTTAACCAAAGTATC 247 95
CTATAGCCATTATCTTTGCA
iceA2 GTTGGGTATATCACAATTTAT 229 95
TTTCCCTATTTTCTAGTAGGT
babA2 CCAAACGAAACAAAAAGCGT 271 94
GCTTGTGTAAAAGCCGTCGTEach PCR of glmM, vacA, cagA, cagE, iceA, and babA2 was
performed in a total volume of 50 ml containing 100 ng
genomic DNA from H. pylori culture or 400 ng genomic
DNA from gastric biopsies in which the RUT was positive,
200 mM each of dNTP (Gibco BRL, USA), 1  PCR buffer
(20 mM Tris-HCl, pH 8.4), 50 mM KCl, 1.5 mM MgCl2 (2 mM
MgCl2 for cagA), 0.5 mM of each primer (0.2 mM for babA2 and
0.3 mM for cagA), and 1.5 units of Taq polymerase (Gibco BRL,
USA). For each batch of PCR assay, distilled water instead of
the genomic DNA templates was used as a negative control.
The reaction mixtures were cycled in an automated ther-
mal cycler (GeneAmp, PCR 2400, Perkin-Elmer, USA) under
the conditions shown in Table 1. After amplification, 10 ml of
PCR product was electrophoresed on 1.5—2% agarose gel,
stained with ethidium bromide, and examined under UV
illuminator.
Data analysis
Fisher’s exact test or the Chi-square test was used for analysis
of categorical data. A p-value of <0.05 was considered
statistically significant.
Results
Helicobacter pylori-infected patients were evaluated for the
relation of age, gender, and ethnic group with the severity of
disease as shown in Table 2. The severity of disease was
diagnosed by endoscopic findings and a pathologist. The
results show that there was no significant difference among
these parameters with regard to the gastroduodenal patientPCR conditions References
8C, 1 min; 55 8C, 1 min; 72 8C, 1 min (35 cycles) 29
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Table 2 Distribution of 112 patients with different clinical outcomes, according to age, gender and ethnic group
Clinical status Total (%)
Non-ulcer GTa (%) (N = 62) Peptic ulcer GCAd (%) (N = 16)
GUb (%) (N = 20) DUc (%) (N = 14)
Age (years)
20 0 (0) 0 (0) 2 (14.3) 0 (0) 2 (1.8)
21—40 16 (25.8) 4 (20) 3 (21.4) 0 (0) 23 (20.5)
41—60 36 (58.1) 11 (55) 6 (42.9) 7 (43.7) 60 (53.6)
>60 10 (16.1) 5 (25) 3 (21.4) 9 (56.3) 27 (24.1)
Gender
Male (M) 28 (45.2) 11 (55) 9 (64.3) 7 (43.7) 55 (49.1)
Female (F) 34 (54.8) 9 (45) 5 (35.7) 9 (56.3) 57 (50.9)
M:F 1:1.2 1:0.8 1:0.6 1:1.3 1:1
Ethnic group
Thai 41 (66.1) 12 (60) 7 (50) 8 (50) 68 (60.7)
Thai-Chinese 15 (24.2) 6 (30) 5 (35.7) 6 (37.5) 32 (28.6)
Chinese 5 (8.1) 2 (10) 2 (14.3) 2 (12.5) 11 (9.8)
Loa-Loa 1 (1.6) 0 (0) 0 (0) 0 (0) 1 (0.9)
a Helicobacter pylori-infected gastritis patients.
b Helicobacter pylori-infected gastric ulcer patients.
c Helicobacter pylori-infected duodenal ulcer patients.
d Helicobacter pylori-infected gastric cancer patients.groups. Nevertheless, the age groups of 41—60 years and>60
years had an increased rate of gastric cancer disease
(Table 2).
The presence of the vacA, cagA, cagE, iceA, and babA2
genes was examined in all 112 of the H. pylori-infected
patients with gastrointestinal diseases. All vacA genes were
the s1 signal sequence allele (100%). The vacA m1 allele and
m2 allele were found in 65 (58%) and 47 (42%) of the samples.
There was no statistical association between vacAs1m1 and
vacAs1m2 and clinical outcome, though the frequency of the
vacAs1m1 allele (64.3%) was higher than the vacAs1m2 allele
(35.7%) in the duodenal ulcer patients ( p > 0.05) (Table 3).
For detection of vacAs1 subtypes, we did not have suffi-
cient template DNA extracted from all of the gastric biopsies
used for detecting several of the genes; we only checked 68
samples (38 gastric biopsies and 30 H. pylori isolates) of the
112 H. pylori-infected patients for the vacAs1 (a, b, c)
subtypes. The results showed that vacAs1c was the predo-
minant genotype in our study albeit there was no significant
difference between the gastroduodenal diseases groups
(data not shown).
The cagA gene was detected in 98.2% (110/112) of the
H. pylori-infected patients. Of the 112 H. pylori-infected
patients, only two (1.8%) showed an absence of cagA, and
those samples were obtained from patients with gastritis.
The cagE gene was detected in 88.4% (99/112) of the H.
pylori-infected patients and was common in all of the patient
groups, similarly to cagA. cagE was found more commonly in
patients with gastric cancer than in the other patient groups
(93.8%; 15/16). The combination of the cagA and cagE gene
was detected in 87.5% (98/112) of the patients (Table 3).
The iceA gene was detected in 78.5% (88/112) of the
H. pylori-infected patients. Of the 88 H. pylori-infectedpatients, iceA1 and iceA2 were detected in 45.5% (51/112)
and 33.1% (37/112), respectively. iceA1 was most commonly
found in the duodenal ulcer patients (57.1%; 8/14), whereas
iceA2 was most commonly found in the gastric ulcer patients
(40%; 8/20). The iceA-negative strain, in which neither iceA1
nor iceA2 was detected, was found in 21.4% of the 112 H.
pylori strains. This finding is similar to that reported by Han
et al.34
The babA2 gene was detected in 92% (103/112) of the H.
pylori-infected patients. The babA2 gene was commonly
found in all patient groups; however, there was no statisti-
cally significant difference in each of the individual genes
among the patient groups ( p > 0.05) (Table 3).
The frequency distributions of the combination genotypes
of H. pylori are presented in Table 4. The four major geno-
types found were: (1) vacAs1m1, cagA, cagE, iceA1, and
babA2 (22.3%); (2) vacAs1m2, cagA, cagE, iceA1, and babA2
(16.1%); (3) vacAs1m1, cagA, cagE, iceA2, and babA2 (15.2%);
and (4) vacAs1m2, cagA, cagE, iceA2, and babA2 (11.6%). No
significant difference was found among the patient groups
( p > 0.05) (Table 4).
Discussion
The clinical relevance of the putative virulence-associated
genes of H. pylori and geographical region is still a matter of
controversy. The present study reported the relationship
between some virulence genes (vacA, cagA, cagE, iceA, babA)
of H. pylori and the clinical status among Thai patients.
All strains ofH. pylori contain the vacA gene, but they vary
in terms of their ability to produce cytotoxin.9 Type s1 andm1
strains demonstrate more toxin activity than s2 and m2
strains.1,12,26,35 In Western studies, the presence of vacAs1
34 C. Chomvarin et al.
Table 3 The vacA, cagA, cagE, iceA, babA2 status of H. pylori strains obtained from 112 patients with different clinical outcomes
Genotypes Clinical status Total (%)
Non-ulcer GTa (%) (N = 62) Peptic ulcer GCAd (%) (N = 16)
GUb (%) (N = 20) DUc (%) (N = 14)
vacA
s1m1 36 (58.1) 12 (60) 9 (64.3) 8 (50) 65 (58)
s1m2 26 (41.9) 8 (40) 5 (35.7) 8 (50) 47 (42)
cagA
Positive 60 (96.8) 20 (100) 14 (100) 16 (100) 110 (98.2)
Negative 2 (3.2) 0 (0) 0 (0) 0 (0) 2 (1.8)
cagE
Positive 54 (87.1) 18 (90) 12 (85.7) 15 (93.8) 99 (88.4)
Negative 8 (12.9) 2 (10) 2 (14.3) 1 (6.2) 13 (11.6)
iceA
iceA1 29 (46.8) 7 (35) 8 (57.1) 7 (43.7) 51 (45.5)
iceA2 19 (30.6) 8 (40) 4 (28.6) 6 (37.5) 37 (33.0)
iceA 14 (22.6) 5 (25) 2 (14.3) 3 (18.8) 24 (21.5)
babA2
Positive 57 (91.9) 17 (85) 14 (100) 15 (93.8) 103 (92)
Negative 5 (8.1) 3 (15) 0 (0) 1 (6.2) 9 (8)
cagA, cagE 53 (85.5) 18 (90) 12 (85.7) 15 (93.8) 98 (87.5)
a Helicobacter pylori-infected gastritis patients.
b Helicobacter pylori-infected gastric ulcer patients.
c Helicobacter pylori-infected duodenal ulcer patients.
d Helicobacter pylori-infected gastric cancer patients.and cagA has been shown to be significantly associated with
peptic ulcers.1,10 However, several studies in Asian popula-
tions have not confirmed this relationship, indicating that
there are important geographic differences.19,27,36 All vacA
genotypes from our 112 H. pylori-infected dyspeptic patients
contained the s1 signal region while 58% and 42% of H. pylori
strains possessed the m1 and m2 middle region, respectively.
Our results are in agreement with previous reports that show
a predominance of s1 in Asian populations; the s1 and m1
were predominant among the vacA subtype of H. pylori
strains.19,37 The cagA-positive vacAs1c-m1 and iceA1 have
been shown to be predominant in Japan and Korea,16,20 while
Qiao et al.30 reported that type s1 of vacA is more common
than type s2, and m1 and m2 are equally represented in the
Xi’an area of China.
The cagA gene has been shown to be present in about
60—70% ofH. pylori strains isolated fromWestern populations
including those of Europe and America.6,9,10 H. pylori cagA-
positive strains have been reported to be associated with
more severe H. pylori disease such as gastric mucosal atrophy
and gastric cancer.9,32,38 In this study, cagA was found in
98.2% of H. pylori-infected dyspeptic patients. This preva-
lence is similar to that reported by others, who have shown
cagA-positive H. pylori in more than 90% of cases in East Asian
countries, and no association with severity of disease.37,39
There was no significant association between either the vacA
subtype or cagA gene and severity of gastroduodenal dis-
eases.37,39 However, recent studies have reported the impor-
tance of the diversity of CagA in relation to gastrointestinaldiseases. They have indicated that the diversity of the
tyrosine CagA phosphorylation occurs at the unique Glu—
Prol—Ile—Ala (EPIYA) motifs present in the C-terminal region,
affected by protein-tyrosine phosphatase (SHP-2), and
actively involved in the regulation of the spreading, migra-
tion, and adhesion of cells. It may induce abnormal prolif-
eration and movement of gastric epithelial cells and be
associated with the mortality rate of gastric cancer in Asia.40
These findings should be further studied in H. pylori cagA-
positive strains isolated from Thai dyspeptic patients in the
future.
The cagE gene, also within the pathogenicity island and
shown to stimulate production of several cytokines from
infected epithelial cells, was found in 88.4% of H. pylori
and 87.5% of cagA-positive H. pylori in this study. This result
corresponds to those found in a previous report on children in
the USA;9 however, we found that when cagA was positive,
cagEwas negative in 10.7% of samples (12/112), whereas only
one sample was cagE-positive and cagA-negative.
The iceA gene may be associated with peptic ulcer dis-
ease;9,18 however, some studies have failed to confirm this
correlation, and some groups have suggested a reverse rela-
tionship.19 There are two distinct allelic variants of iceA,
namely iceA1 and iceA2.7,19,37 One study has suggested that
iceA1 is associated with the development of peptic ulcers,
and that iceA1-positive strains produce more of the proin-
flammatory factor IL-8 than iceA1-negative strains.41 Peek
et al.18 demonstrated that iceA1 expression is significantly
related to the host mucosal response, which led to the
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Table 4 Frequency distribution of combination genotypes of 112 H. pylori in the gastrointestinal dyspeptic patients
Combination genotypes Clinical status Total (%)
Non-ulcer GTa (%)
(N = 62)
Peptic ulcer GCAd (%)
(N = 16)
GUb (%) (N = 20) DUc (%) (N = 14)
vacAs1m1, cagA, cagE, iceA1, babA2 13 (21) 4 (20) 5 (35.7) 3 (18.8) 25 (22.3)
vacAs1m2, cagA, cagE, iceA1, babA2 11 (17.7) 2 (10) 2 (14.3) 3 (18.8) 18 (16.1)
vacAs1m1, cagA, cagE, iceA2, babA2 11 (17.7) 1 (5) 1 (7.1) 4 (25) 17 (15.2)
vacAs1m2, cagA, cagE, iceA2, babA2 4 (6.5) 5 (25) 2 (14.3) 2 (12.5) 13 (11.6)
Others 23 (37.1) 8 (40) 4 (28.6) 4 (25) 39 (34.8)
Total 62 (100) 20 (100) 14 (100) 16 (100) 112 (100)
a Helicobacter pylori-infected gastritis patients.
b Helicobacter pylori-infected gastric ulcer patients.
c Helicobacter pylori-infected duodenal ulcer patients.
d Helicobacter pylori-infected gastric cancer patients.hypothesis that the levels of transcription within the host
environment may contribute to disease development. In
contrast, iceA2 expression may be more influenced by gene
structure, which has a repeated protein structure but it does
not have homology with known proteins. Indeed, our H.
pylori study of the iceA allele demonstrated that iceA1
(45.5%) was the most frequent genotype detected in our
population. This finding agrees with previous reports that
have shown the iceA1 allele more frequently found than the
iceA2 allele in Chinese, Japanese, Korean and Dutch
patients;7,19,34,37 iceA2 has been found to be predominant
among Brazilian, European and American patients.9,19,42
The babA2 gene has been shown to be associated with a
higher risk of ulcer or adenocarcinoma development, and has
been strongly associated with vacAs1 (79% babA2-positive)
and cagA genotypes (80% babA2-positive) in German adults.21
H. pylori with triple positive genotypes, vacAs1, cagA and
babA2, has been reported in only 31% of dyspeptic children
with H. pylori infection.10 A previous study showed that H.
pylori strains carrying babA2, cagA, and vacAs1m1 genotype
were associated with the highest risk of developing intestinal
metaplasia.27 We, however, did not find any specific disease
association between H. pylori genotype and the clinical
outcome of infection, even though all of our H. pylori had
vacAs1, 92% babA2 and 98% cagA. Our results agree with Kim
et al.,37 who did not find any association with cagA, vacA
subtype, iceA1 and babA of H. pylori isolates from Korean
patients, and Han et al.34 who also did not find any associa-
tion with iceA1 and babA2 of H. pylori isolates from Shanghai
patients.
Several factors involved in the pathogenesis of H. pylori
have been studied, including bacterial genotypes.1,7,9,10 We
found a high prevalence of vacAs1, cagA, cagE, iceA and
babA2 in our H. pylori-infected dyspeptic patients in accord
with research in other East Asian countries,19,30,37 and no
significant difference was found between the various genes
and severity of diseases.
Past studies have reported high incidences of gastric
cancer among Japanese and Chinese people and very low
incidences in the Thai and Vietnamese populations.43 In fact,
we found no significant difference between the various genes
and severity of diseases, indicating that the presence of cagA
or subtypes of vacA cannot serve as real virulencemarkers forthe development of gastric cancer, as was found in Japan and
Korea.
In conclusion, this is the first report of the high prevalence
of H. pylori virulence genes in Thai dyspeptic patients. There
was no significant difference in any one specific bacterial
gene and the gene pattern being associated with a particular
clinical outcome. It is therefore necessary to define both the
environmental and host factors in association with the bac-
terial characteristics for use in the prediction of the severity
of disease.
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